Prevalence of cardiovascular sequelae after COVID-19 - REBOUH, Amel Leila;AITSEDDIK, Sarah;Belkaid, Rosa
44,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
22 °P sammeln
  • Broschiertes Buch

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), called Coronavirus Disease 2019 (COVID-19) by the World Health Organization, was detected as a novel betacoronavirus infection in Wuhan, China on December 12, 2019 before spreading globally. More and more publications are finding cardiovascular lesions that were not present on admission.The question posed is: "Once recovered from COVID-19, what happens to patients cardiovascularly and what impact does the virus have on the cardiovascular system?".

Andere Kunden interessierten sich auch für
Produktbeschreibung
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), called Coronavirus Disease 2019 (COVID-19) by the World Health Organization, was detected as a novel betacoronavirus infection in Wuhan, China on December 12, 2019 before spreading globally. More and more publications are finding cardiovascular lesions that were not present on admission.The question posed is: "Once recovered from COVID-19, what happens to patients cardiovascularly and what impact does the virus have on the cardiovascular system?".
Autorenporträt
La Dra. Amel Leila REBOUH es licenciada por la Facultad de Medicina de Argel, donde imparte clases de Epidemiología y Medicina Preventiva desde 2018. Trabajó en el Institut National de Santé Publique antes de incorporarse al Centre Hospitalier Universitaire de Béni Messous.